Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Strategies for In Vivo Administration: Part-II

Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Strategies for In Vivo Administration: Part-II

Diabetes is a complex disease characterized by hyperglycemia, together with polyuria, polydipsia, and polyphagia. While Type 1 diabetes mellitus (T1DM) results from genetic, environmental, or immune dysfunction factors leading to pancreatic β-cell destruction depriving the organism from end...

Full description

Bibliographic Details
Main Authors: Raquel Vieira, Selma B. Souto, Elena Sánchez-López, Ana López Machado, Patricia Severino, Sajan Jose, Antonello Santini, Amelia M. Silva, Ana Fortuna, Maria Luisa García, Eliana B. Souto
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Journal of Clinical Medicine
Subjects:
diabetes mellitus
animal models
in vivo
administration routes
Online Access:https://www.mdpi.com/2077-0383/8/9/1332

Internet

https://www.mdpi.com/2077-0383/8/9/1332

Similar Items